GlassScriptPhysician profile
Annabelle Storch
NPI 1275197519
$2,094.47
in general payments reported to CMS, 2019-2025
13 companies · $1,034 in 2025
The $1,034 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2021: $19.70 · 2022: $145 · 2023: $273 · 2024: $511 · 2025: $1,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,818.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $299.57 | 2021-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Sun Pharmaceutical Industries INC. | $295.29 | 2024-2025 | |
| Rxsight INC | $239.97 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Bausch & Lomb Americas INC. | $237.22 | 2023-2025 | Miebo |
| Harrow Eye, LLC | $219.29 | 2024-2025 | Vevye |
| Dompe US, INC. | $142.95 | 2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $142.14 | 2025 | |
| Alcon Vision LLC | $137.19 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $125.00 | 2025 | |
| Kala Pharmaceuticals, INC. | $124.99 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $66.35 | 2019 | |
| Allergan, INC. | $44.25 | 2019 | |
| Coopervision INC. | $20.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annabelle Storch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.